Nukkleus (NASDAQ:NUKK) & Exponent (NASDAQ:EXPO) Head-To-Head Review

Nukkleus (NASDAQ:NUKK) and Exponent (NASDAQ:EXPO) are both business services companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk.

Profitability

This table compares Nukkleus and Exponent’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nukkleus	N/A	N/A	-4.47%
Exponent	18.69%	28.49%	16.58%

Analyst Ratings

This is a breakdown of recent ratings and target prices for Nukkleus and Exponent, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nukkleus	0	0	0	0	N/A
Exponent	0	1	1	0	2.50

Exponent has a consensus price target of $97.00, suggesting a potential upside of 22.52%. Given Exponent’s higher probable upside, analysts clearly believe Exponent is more favorable than Nukkleus.

Earnings and Valuation

This table compares Nukkleus and Exponent’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nukkleus	N/A	N/A	-$970,000.00	N/A	N/A
Exponent	$536.77 million	7.46	$100.34 million	$1.95	40.60

Exponent has higher revenue and earnings than Nukkleus.

Risk and Volatility

Nukkleus has a beta of -0.32, suggesting that its share price is 132% less volatile than the S&P 500. Comparatively, Exponent has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500.

Insider & Institutional Ownership

12.5% of Nukkleus shares are owned by institutional investors. Comparatively, 92.4% of Exponent shares are owned by institutional investors. 69.8% of Nukkleus shares are owned by company insiders. Comparatively, 2.2% of Exponent shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Exponent beats Nukkleus on 9 of the 10 factors compared between the two stocks.

About Nukkleus

Nukkleus Inc., a financial technology company, focuses on providing software and technology solutions for retail foreign exchange trading industry worldwide. The company primarily offers software, technology, customer sales and marketing, and risk management technology hardware and software solutions. It also offers payment services from one fiat currency to another or to digital assets. The company was founded in 2013 and is headquartered in Jersey City, New Jersey. Nukkleus Inc. operates as a subsidiary of Global Elite Holdings Ltd.

About Exponent

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.